Studies evaluating ferric derisomaltose in iron deficiency anemia in specific patient populations with a focus on iron repletion approaches. These studies contribute to the understanding of iron deficiency anemia management across patient groups with distinct clinical and physiological considerations.

This section includes links to Pharmacosmos-sponsored publications and selected Pharmacosmos posters. Information contained in these publications may include information that is inconsistent with the FDA approved use of product(s). Pharmacosmos does not recommend the use of its products in a manner that is inconsistent with FDA-approved labeling. Additionally, the content contained in this section is subject to congress copyright permissions.